Literature DB >> 3161204

Pulmonary changes in congenital heart disease with Down's syndrome: their significance as a cause of postoperative respiratory failure.

S Yamaki, T Horiuchi, T Takahashi.   

Abstract

Biopsy or necropsy specimens of lung from 28 patients with congenital heart disease and Down's syndrome were studied to establish the cause of the postoperative respiratory failure often seen in such cases. Changes in lungs seen after operation included interstitial emphysema and overdistension of peripheral air spaces, associated with hypoplastic alveoli and deficient elastic fibres in the alveolar wall. In specimens taken before operation alveolar hypoplasia was common but interstitial emphysema or overdistension of lower airways was found only rarely. Findings suggest that alveolar hypoplasia is characteristic of Down's syndrome and that distension of peripheral air spaces or interstitial emphysema was due to artificial inflation of the lung during surgery. The severity of the lesions correlated significantly with the duration of artificial respiration and with the severity of the respiratory failure. Hypoplastic lung tissue in patients with Down's syndrome appears to be more susceptible to mechanical stress, and this is likely to be the cause of postoperative respiratory failure.

Entities:  

Mesh:

Year:  1985        PMID: 3161204      PMCID: PMC460071          DOI: 10.1136/thx.40.5.380

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  8 in total

1.  The number of alveoli in the terminal respiratory unit of man during late intrauterine life and childhood.

Authors:  J L EMERY; A MITHAL
Journal:  Arch Dis Child       Date:  1960-12       Impact factor: 3.791

2.  Clinical aspects of congenital heart disease in mongolism.

Authors:  R M Shaher; M A Farina; I H Porter; M Bishop
Journal:  Am J Cardiol       Date:  1972-04       Impact factor: 2.778

3.  Quantitative analysis of pulmonary vascular disease in simple cardiac anomalies with the Down syndrome.

Authors:  S Yamaki; T Horiuchi; Y Sekino
Journal:  Am J Cardiol       Date:  1983-05-15       Impact factor: 2.778

4.  The pulmonary vascular bed in children with Down syndrome.

Authors:  J Chi TPL?Krovetz
Journal:  J Pediatr       Date:  1975-04       Impact factor: 4.406

5.  Postnatal human lung growth.

Authors:  W M Thurlbeck
Journal:  Thorax       Date:  1982-08       Impact factor: 9.139

6.  Lung pathology in infants with severe pulmonary hypertension and cardiac disease.

Authors:  K Ogawa; H Ito; A Toriyama; T Yamamoto; M Yamaguchi; K Horikoshi; S Asada
Journal:  J Thorac Cardiovasc Surg       Date:  1979-05       Impact factor: 5.209

7.  Pulmonary hypoplasia in Down's syndrome.

Authors:  T P Cooney; W M Thurlbeck
Journal:  N Engl J Med       Date:  1982-11-04       Impact factor: 91.245

8.  The clinical course of cardiac disease in Down's syndrome.

Authors:  R D Greenwood; A S Nadas
Journal:  Pediatrics       Date:  1976-12       Impact factor: 7.124

  8 in total
  4 in total

1.  Modern age pathology of pulmonary arterial hypertension.

Authors:  Elvira Stacher; Brian B Graham; James M Hunt; Aneta Gandjeva; Steve D Groshong; Vallerie V McLaughlin; Marsha Jessup; William E Grizzle; Michaela A Aldred; Carlyne D Cool; Rubin M Tuder
Journal:  Am J Respir Crit Care Med       Date:  2012-06-07       Impact factor: 21.405

Review 2.  Pulmonary hypertension in children: perioperative management.

Authors:  F A Burrows; J R Klinck; M Rabinovitch; D J Bohn
Journal:  Can Anaesth Soc J       Date:  1986-09

3.  Comparison of hemodynamic data before and after corrective surgery for Down's syndrome and ventricular septal defect.

Authors:  T Kawai; Y Wada; T Enmoto; K Nishiyama; K Kitaura; S Sato; T Oka
Journal:  Heart Vessels       Date:  1995       Impact factor: 2.037

4.  Prolonged postoperative desaturation in a child with Down syndrome and atrial septal defect.

Authors:  Renu Sinha; Chitra Rajeswari Thangaswamy; Thilaka Muthiah; Parul Chandra; Rajeshwari Subramaniam
Journal:  Indian J Anaesth       Date:  2011-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.